Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Acad Med ; 93(7): 1002-1013, 2018 07.
Article in English | MEDLINE | ID: mdl-29239903

ABSTRACT

Graduate medical education (GME) in the United States is financed by contributions from both federal and state entities that total over $15 billion annually. Within institutions, these funds are distributed with limited transparency to achieve ill-defined outcomes. To address this, the Institute of Medicine convened a committee on the governance and financing of GME to recommend finance reform that would promote a physician training system that meets society's current and future needs. The resulting report provided several recommendations regarding the oversight and mechanisms of GME funding, including implementation of performance-based GME payments, but did not provide specific details about the content and development of metrics for these payments. To initiate a national conversation about performance-based GME funding, the authors asked: What should GME be held accountable for in exchange for public funding? In answer to this question, the authors propose 17 potential performance-based metrics for GME funding that could inform future funding decisions. Eight of the metrics are described as exemplars to add context and to help readers obtain a deeper understanding of the inherent complexities of performance-based GME funding. The authors also describe considerations and precautions for metric implementation.


Subject(s)
Capital Financing/methods , Education, Medical, Graduate/economics , Reimbursement, Incentive/trends , Capital Financing/trends , Education, Medical, Graduate/trends , Humans , National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division/organization & administration , Training Support/economics , United States
4.
J Gen Intern Med ; 23(8): 1152-6, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18459009

ABSTRACT

BACKGROUND: Primary prevention of intimate partner violence (IPV) at the level of the primary care provider is unexplored. OBJECTIVE: We sought to identify whether men disclose current IPV perpetration when asked by a primary care provider. DESIGN: Cross-sectional study. PARTICIPANTS: Consecutive male patients of 6 providers in public health, university, and VA hospital clinics. MEASUREMENTS: Men were screened for IPV perpetration during routine visits, then given a Conflict Tactics Scale questionnaire (CTS2) to complete and mail back anonymously. RESULTS: One hundred twenty-eight men were screened; 46 (36%) returned CTS2 questionnaires. Twenty-three and 2 men disclosed past and current perpetration to providers, respectively. Providers assessed lethality/safety issues in 58% of those reporting a perpetration history (including both with current perpetration), responded with direct counseling to 63% (including both with current perpetration), and referred 17% for services related to the screening (including 1 with current perpetration). Nine and 26 men reported current, CTS2-assessed physical and psychological aggression of a partner, respectively. CONCLUSIONS: Men appear to underreport current IPV perpetration in face-to-face primary care encounters when compared to other methods of reporting. Men may more readily report past IPV perpetration in face-to-face encounters.


Subject(s)
Domestic Violence/statistics & numerical data , Mass Screening , Primary Health Care , Adolescent , Adult , Aged , Aged, 80 and over , Chi-Square Distribution , Cross-Sectional Studies , Humans , Likelihood Functions , Male , Middle Aged , Surveys and Questionnaires
5.
Cleve Clin J Med ; 71(3): 233-9, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15055246

ABSTRACT

Fitz-Hugh-Curtis syndrome--inflammation of the liver capsule associated with genital tract infection--occurs in up to one fourth of patients with pelvic inflammatory disease (PID). Classically presenting as sharp, pleuritic right upper quadrant pain, usually but not always accompanied by signs of salpingitis, it can mimic many other common disorders such as cholecystitis and pyelonephritis.


Subject(s)
Abdominal Pain/etiology , Hepatitis/diagnosis , Pelvic Inflammatory Disease/diagnosis , Anti-Bacterial Agents/therapeutic use , Cefotetan/therapeutic use , Diagnosis, Differential , Female , Gonorrhea/drug therapy , Hepatitis/etiology , Humans , Pelvic Inflammatory Disease/complications , Pelvic Inflammatory Disease/drug therapy , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...